Illumina

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Illumina 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. 

CEO
Jacob Thaysen
CEOJacob Thaysen
Employees
10,370
Employees10,370
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1998
Founded1998
Employees
10,370
Employees10,370

ILMN Key Statistics

Market cap
18.63B
Market cap18.63B
Price-Earnings ratio
27.31
Price-Earnings ratio27.31
Dividend yield
Dividend yield
Average volume
2.50M
Average volume2.50M
High today
$122.08
High today$122.08
Low today
$119.10
Low today$119.10
Open price
$120.21
Open price$120.21
Volume
1.13M
Volume1.13M
52 Week high
$154.43
52 Week high$154.43
52 Week low
$68.70
52 Week low$68.70

Stock Snapshot

The current Illumina(ILMN) stock price is $122.00, with a market capitalization of 18.63B. The stock trades at a price-to-earnings (P/E) ratio of 27.31.

During the trading session on 2025-11-09, Illumina(ILMN) shares reached a daily high of $122.08 and a low of $119.10. At a current price of $122.00, the stock is +2.4% higher than the low and still -0.1% under the high.

Trading volume for Illumina(ILMN) stock has reached 1.13M, versus its average volume of 2.5M.

The stock's 52-week range extends from a low of $68.70 to a high of $154.43.

The stock's 52-week range extends from a low of $68.70 to a high of $154.43.

ILMN News

Simply Wall St 2d
Illumina Valuation: How Recent Earnings and China Export News Are Shaping Investor Expectations

Illumina has captured fresh attention this week after delivering strong third quarter earnings and raising its full-year revenue outlook. The Chinese Ministry o...

Illumina Valuation: How Recent Earnings and China Export News Are Shaping Investor Expectations
TipRanks 3d
Chinese Ministry of Commerce to lift export ban on Illumina

The Chinese Ministry of Commerce announced it will lift the export ban on Illumina (ILMN) which had been in place since March 4, 2025. While the ban will be lif...

Benzinga 6d
Biotech ETFs Come Alive As Illumina Soars 23% — Is The Genomics Winter Finally Over?

Biotech investors finally got a dose of good news this week. Illumina Inc (NASDAQ:ILMN) staged a powerful comeback, with the stock surging over 23% on Friday af...

Biotech ETFs Come Alive As Illumina Soars 23% — Is The Genomics Winter Finally Over?

Analyst ratings

46%

of 24 ratings
Buy
41.7%
Hold
45.8%
Sell
12.5%

More ILMN News

Simply Wall St 6d
Does Illumina's Raised 2025 Outlook Reinforce Confidence in Its Long-Term Growth Story?

In October 2025, Illumina announced higher full-year 2025 earnings guidance, projecting revenue between US$4.27 billion and US$4.31 billion, alongside its third...

Does Illumina's Raised 2025 Outlook Reinforce Confidence in Its Long-Term Growth Story?

People also own

Based on the portfolios of people who own ILMN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.